Create account

Coverage dated December 22, 2021 to December 23, 2021

US adds Merck pill as 2nd easy-to-use drug against COVID-19

Headline from The Daily Nonpareil

WASHINGTON — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.

The Daily Nonpareil's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

97 articles, oldest first.

  1. KVIA El Paso

    FDA authorizes second antiviral pill to treat Covid-19 (opens KVIA El Paso)

    Published

    KVIA El Paso's feed description

    By Jamie Gumbrecht, Amanda Sealy and Jacqueline Howard, CNN The US Food and Drug Administration on Thursday authorized Merck’s antiviral pill, molnupiravir, to treat Covid-19 “for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 vi…

  2. KTVU San Francisco

    Merck COVID-19 pill: FDA approves 2nd at-home treatment (opens KTVU San Francisco)

    Published

    KTVU San Francisco's feed description

    Merck’s COVID-19 pill has been authorized by the FDA, providing another easy-to-use medication to fight the rapidly-spreading omicron variant.

  3. The Daily Nonpareil

    US adds Merck pill as 2nd easy-to-use drug against COVID-19 (opens The Daily Nonpareil)

    Published

    The Daily Nonpareil's feed description

    WASHINGTON — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.

  4. FOX Business

    FDA authorizes second COVID-19 antiviral pill, Merck's molnupiravir (opens FOX Business)

    Published

    FOX Business's feed description

    The Food and Drug Administration on Thursday authorized the use of Merck's molnupiravir pill for treating COVID-19, the second such emergency use authorization in two days.

  5. WHEC Rochester

    Second COVID-19 pill authorized by FDA (opens WHEC Rochester)

    Published

    WHEC Rochester's feed description

    U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.

  6. KEZI Eugene

    U.S. adds Merck pill as second easy-to-use drug against COVID-19 (opens KEZI Eugene)

    Published

    KEZI Eugene's feed description

    The approval comes after the FDA greenlighted a more effective pill from Pfizer.

  7. Triblive

    U.S. adds Merck's covid pill as 2nd easy-to-use drug against virus (opens Triblive)

    Published

    Triblive's feed description

    WASHINGTON — U.S. health regulators on Thursday authorized the second pill against covid-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer.

  8. Washington Times

    U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19 (opens Washington Times)

    Published

    Washington Times's feed description

    U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.

  9. CBS News

    FDA authorizes second COVID antiviral pill, from Merck, if no alternatives available (opens CBS News)

    Published

    CBS News's feed description

    The White House expects millions of courses of the drug from Merck and Ridgeback Biotherapeutics by the end of January.

  10. WMUR

    Merck's COVID-19 pill becomes second to earn US approval (opens WMUR)

    Published

    WMUR's feed description

    As the nation faces another surge, there are now two COVID-19 pills that have received the FDA's stamp of approval.

  11. Washington Post

    FDA authorizes Merck’s anti-coronavirus pill, a second treatment option (opens Washington Post)

    Published

    Washington Post's feed description

    Merck's anti-covid pill, molnupiravir, was authorized by federal regulators a day after Pfizer's pill received a green light. Molnupiravir carries risks, but with treatments in short supply, it may be the only option available.

  12. The Hill

    FDA authorizes second COVID-19 pill, from Merck (opens The Hill)

    Published

    The Hill's feed description

    The Food and Drug Administration on Thursday authorized a COVID-19 treatment from Merck, marking the second pill to become available to fight the virus.

  13. Engadget

    Merck's COVID-19 antiviral pill is the second authorized by the FDA (opens Engadget)

    Published

    Engadget's feed description

    The FDA has approved a second COVID-19 antiviral pill, but Merck's offering might not get as much uptake as its Pfizer rival..

  14. Forbes

    FDA Approves Merck's Antiviral Pill For Emergency Use (opens Forbes)

    Published

    Forbes's feed description

    Merck’s antiviral pill is 30% effective at preventing hospitalizations.

  15. Portland Press Herald

    FDA authorizes Merck anti-viral pill, 2nd easy-to-use COVID-19 drug (opens Portland Press Herald)

    Published

    Portland Press Herald's feed description

    The authorization comes one day after the agency cleared a competing drug from Pfizer.

  16. Politico

    FDA authorizes Merck’s Covid-19 pill (opens Politico)

    Published

    Politico's feed description

    Clinical trials showed that Merck’s pill reduced the risk of hospitalization and death from the virus by 30 percent.

  17. Hiawatha World Online

    FDA Gives OK to Merck Antiviral At-Home COVID-19 Pill (opens Hiawatha World Online)

    Published

    Hiawatha World Online's feed description

    THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19. The U.S.

  18. France 24

    US regulator authorizes Merck's Covid pill (opens France 24)

    Published

    France 24's feed description

    The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after giving the green light to a similar pill by Pfizer.

  19. New Hampshire Union Leader

    U.S. authorizes Merck pill as second at-home COVID-19 treatment (opens New Hampshire Union Leader)

    Published

    New Hampshire Union Leader's feed description

    The U.S. on Thursday authorized Merck & Co.’s antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective

  20. PBS NewsHour

    FDA authorizes Merck's pill against COVID-19 (opens PBS NewsHour)

    Published

    PBS NewsHour's feed description

    The Food and Drug Administration authorization of Merck's molnupiravir comes one day after the agency cleared a competing drug from Pfizer.

  21. The Times of Israel

    US approves Merck pill as 2nd easy-to-use drug against COVID-19 (opens The Times of Israel)

    Published

    The Times of Israel's feed description

    FDA authorizes molnupiravir for combating severe coronavirus infections; will have smaller role than Pfizer's more effective Paxlovid

  22. Al Jazeera

    US approves Merck drug as second at-home COVID-19 antiviral pill (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer.

  23. St. Louis Post-Dispatch

    FDA Gives OK to Merck's Antiviral At-Home COVID Pill (opens St. Louis Post-Dispatch)

    Published

    St. Louis Post-Dispatch's feed description

    THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19.

  24. The Week

    FDA authorizes a 2nd pill to treat COVID-19 (opens The Week)

    Published

  25. Delaware Public Media

    FDA authorizes a 2nd easy-to-use COVID treatment, Merck's antiviral pill (opens Delaware Public Media)

    Published

    Delaware Public Media's feed description

    The Food and Drug Administration has granted Emergency Use Authorization to a second COVID-19 antiviral therapy. This one comes from drug maker Merck.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

US adds Merck pill as 2nd easy-to-use drug against COVID-19 | Since Then